A Study of RNK08954 in Subjects With Advanced Solid Tumors With KRAS ((Kirsten Rat Sarcoma) G12D Mutation
A Study of RNK08954 in Subjects With Advanced Solid Tumors With KRAS ((Kirsten Rat Sarcoma) G12D Mutation
Recruiting · NCT06667544 · Registry updated 2025-10-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of RNK08954 in Subjects With Advanced Solid Tumors With KRAS ((Kirsten Rat Sarcoma) G12D Mutation | KRAS G12D Mutation | Recruiting | Phase 1 / Phase 2 | 2025-10-30 | NCT06667544 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ranok Therapeutics (Hangzhou) Co., Ltd. | 4 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Guangxi Medical University Cancer Hospital | Nanning | China | 24 |
| Henan Cancer Hospital | Zhengzhou | China | 98 |
| Ruijin Hospital, Shanghai Jiaotong University School of Medicine | Shanghai | China | 21 |
| Shanghai Chest Hospital | Shanghai | China | 56 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan | China | 54 |
| Zhejiang Cancer Hospital | Hangzhou | China | 84 |